Aprogen Biologics Inc. (003060.KS) KSC

Currency In KRW

AD

Valuation

Market Cap102.98B
Enterprise Value303.91B
P/E Ratio-0.25
PEG Ratio-0
Price/Sales Ratio0.22
Price/Book Ratio0.1
Enterprise/Revenue2.41
Enterprise/EBITDA-7.48

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin-0.91
Operating Margin-1.38
AD

Management Effectiveness

Return On Assets-0.14
Return On Equity-0.37

Income Statement

Revenue73.23B
Revenue/Share6,161.03
Gross Profit-28.42B
EBITDA-103.7B
Net Income-170.33B
Diluted EPS-12,931

Balance Sheet

Total Cash22.7B
Total Cash/Share1,622.7
Total Debt210.84B
Total Debt/Equity1.09
Current Ratio0.57
Book Value Per Share19,401.19

Price History

52-Week Change-83.06
52-Week High9,940.03
52-Week Low1,424
Moving Average 50 Days1,727.7
Moving Average 200 Days3,580.63

Statistics

Average Volume314,886
Shares Outstanding13.18M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor667:10000
Last Split DateApril 13, 2026
AD